Novartis sales rise, board endorses Sandoz spinoff plan
Outside of the upcoming Sandoz spinoff, Novartis also raised its full-year group guidance based on its performance in the first half of 2023.
Source: mmm-online.com
Page 4 - Dtx Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Dtx Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Dtx Pharma Today - Breaking & Trending Today
Novartis : builds on neuroscience pipeline and xRNA platform capabilities with acquisition of DTx Pharma
DTx Pharma is a preclinical stage biotechnology company that focuses on developing siRNA therapies for neuroscience indications, leveraging its proprietary fatty acid...
Source: marketscreener.com
Novartis Buys DTx Pharma for $500 Million Plus Milestone Payments
By Cecilia Butini Novartis will buy U.S.-based biotechnology company DTx Pharma for $500 million plus additional payments when certain scientific milestones are completed, the Swiss pharma...
Source: marketscreener.com
Novartis Adds FALCON Platform To SiRNA Toolkit With Acquisition Of DTx Pharma
Novartis (NVS) has acquired DTx Pharma, a preclinical stage biotechnology company focused on leveraging its FALCON platform to develop siRNA therapies for neuroscience indications.
Source: rttnews.com